Literature DB >> 11331918

Research and treatment approaches to depression.

M L Wong1, J Licinio.   

Abstract

Depression is a major cause of disability worldwide, but we know little about the underlying fundamental biology. Research is hindered by the difficulties of modelling a disorder of higher cognitive functions in animals. Depression can be understood as the interaction of genetic susceptibility and environmental factors; however, current classifications are purely descriptive. The complexity of this field is best approached by rigorous explorations of known candidate systems in conjunction with the use of genomic tools to discover new targets for antidepressants and to predict therapeutic outcomes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331918     DOI: 10.1038/35072566

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  148 in total

1.  Adult human neurogenesis: from microscopy to magnetic resonance imaging.

Authors:  Amanda Sierra; Juan M Encinas; Mirjana Maletic-Savatic
Journal:  Front Neurosci       Date:  2011-04-04       Impact factor: 4.677

Review 2.  Is there a personalized medicine for mood disorders?

Authors:  Lucie Bartova; Andreas Berger; Lukas Pezawas
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-10-19       Impact factor: 5.270

Review 3.  Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions.

Authors:  Richard S Jope; Myoung-Sun Roh
Journal:  Curr Drug Targets       Date:  2006-11       Impact factor: 3.465

4.  Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter.

Authors:  Brent J Thompson; Tammy Jessen; L K Henry; Julie R Field; Karen L Gamble; Paul J Gresch; Ana M Carneiro; Rebecca E Horton; Peter J Chisnell; Yekaterina Belova; Douglas G McMahon; Lynette C Daws; Randy D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

5.  Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling.

Authors:  T Couroussé; A Bacq; C Belzung; B Guiard; L Balasse; F Louis; A-M Le Guisquet; A M Gardier; A H Schinkel; B Giros; S Gautron
Journal:  Mol Psychiatry       Date:  2014-08-05       Impact factor: 15.992

6.  An extract of Synedrella nodiflora (L) Gaertn exhibits antidepressant properties through monoaminergic mechanisms.

Authors:  Patrick Amoateng; Kennedy Kwami Edem Kukuia; Jeffrey Amoako Mensah; Dorcas Osei-Safo; Samuel Adjei; Audrey Akyea Eklemet; Emmanuel Atsu Vinyo; Thomas K Karikari
Journal:  Metab Brain Dis       Date:  2018-05-12       Impact factor: 3.584

7.  Fucoidan prevents depression-like behavior in rats exposed to repeated restraint stress.

Authors:  Bombi Lee; Insop Shim; Hyejung Lee; Dae-Hyun Hahm
Journal:  J Nat Med       Date:  2012-10-23       Impact factor: 2.343

Review 8.  Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.

Authors:  Katherine I Morley; Wayne D Hall
Journal:  J Mol Med (Berl)       Date:  2003-11-04       Impact factor: 4.599

9.  Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy.

Authors:  Megumi Adachi; Michel Barrot; Anita E Autry; David Theobald; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2007-11-05       Impact factor: 13.382

10.  Depressive-like behavior in mice recently recovered from motor disorders after 3-nitropropionic acid intoxication.

Authors:  Xiao-Min Li; Bing-Gen Zhu; Sha Ma; Wei Zhou; Zheng Wei; Yu-Xiang Zheng; Xu-Dong Zhao; Rong-Shen Zhu
Journal:  Neurosci Bull       Date:  2008-08       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.